Iluvien, a sustained release drug-delivery system for the treatment of diabetic macular edema, may be getting closer to possible FDA approval. The parent company, Alimera Sciences has resubmitted additional safety and efficacy data as requested by the FDA last year. …
Tag: corticosteroid
Iluvien Update: FDA Marketing Approval Delayed
Last July, I wrote a comprehensive report about Iluvien and the status and promise of other sustained release drug delivery systems (Iluvien and the Future of Ophthalmic Drug Delivery Systems). At that time, Alimera Sciences, the company developing Ilu…
Treatment of Seasonal Allergic Conjunctivitis With Ophthalmic Corticosteroids: In Search of the Perfect Ocular Corticosteroids in the Treatment of Allergic Conjunctivitis
Learn more about the newer ophthalmic corticosteroid formulations for conjunctivitis and their improved safety profile. Current Opinion in Allergy and Clinical Immunology